Preventing chronic disease: an important investment, but don't count on cost savings.

Over the four decades since cost-effectiveness analysis was first applied to health and medicine, hundreds of studies have shown that prevention usually adds to medical costs instead of reducing them. Medications for hypertension and elevated cholesterol, diet and exercise to prevent diabetes, and screening and early treatment for cancer all add more to medical costs than they save. Careful choices about frequency, groups to target, and component costs can increase the likelihood that interventions will be highly cost-effective or even cost-saving.

[1]  C. Whitney,et al.  Cost-Effectiveness of Vaccination against Invasive Pneumococcal Disease among People 50 through 64 Years of Age: Role of Comorbid Conditions and Race , 2003, Annals of Internal Medicine.

[2]  L. Prosser,et al.  Cost-Effectiveness of Cholesterol-Lowering Therapies according to Selected Patient Characteristics , 2000, Annals of Internal Medicine.

[3]  Joshua T. Cohen,et al.  Does preventive care save money? Health economics and the presidential candidates. , 2008, The New England journal of medicine.

[4]  Louise B. Russell,et al.  Is Prevention Better Than Cure , 1987 .

[5]  L. Goldman,et al.  Long-term cost-effectiveness of various initial monotherapies for mild to moderate hypertension. , 1990, JAMA.

[6]  T. Valle,et al.  Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. , 2001, The New England journal of medicine.

[7]  Michael Pignone,et al.  Aspirin, Statins, or Both Drugs for the Primary Prevention of Coronary Heart Disease Events in Men: A CostUtility Analysis , 2006, Annals of Internal Medicine.

[8]  D. Atkins,et al.  The Cost-Effectiveness of Screening Mammography beyond Age 65 Years , 2003, Annals of Internal Medicine.

[9]  Milton C. Weinstein,et al.  Hypertension: A Policy Perspective , 1976 .

[10]  D. Eddy Screening for cervical cancer. , 1990, Annals of internal medicine.

[11]  K. Ensrud,et al.  Universal Bone Densitometry Screening Combined with Alendronate Therapy for Those Diagnosed with Osteoporosis Is Highly Cost‐Effective for Elderly Women , 2005, Journal of the American Geriatrics Society.

[12]  David M Eddy,et al.  Clinical Outcomes and Cost-Effectiveness of Strategies for Managing People at High Risk for Diabetes , 2005, Annals of Internal Medicine.

[13]  Robert L Kane,et al.  Cost-effectiveness of bone densitometry followed by treatment of osteoporosis in older men. , 2007, JAMA.

[14]  Michael Pignone,et al.  Aspirin for the primary prevention of cardiovascular disease in women: a cost-utility analysis. , 2007, Archives of internal medicine.